{
    "clinical_study": {
        "@rank": "43536", 
        "brief_summary": {
            "textblock": "The aim is to set up tools that will serve as quality tracers for cryopreservation\n      procedures.\n\n      To meet this objective, we have chosen to develop reference samples (sentinel cells) that,\n      in the medium term, can be used as controls to guarantee the quality of preservation for\n      biological samples.\n\n      The biological tools and an optimised follow-up strategy will make it possible to validate\n      preservation procedures at the CRB in order to guarantee the perfect stability of samples\n      and the validity of clinical studies."
        }, 
        "brief_title": "Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation", 
        "completion_date": {
            "#text": "August 2009", 
            "@type": "Actual"
        }, 
        "condition": "Aneurysm of the Abdominal Aorta", 
        "condition_browse": {
            "mesh_term": "Aneurysm"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > or = 18 years\n\n          -  All patients presenting an abdominal aorta diameter of at least 5 cm at the time of\n             discovery and who have surgery\n\n        Exclusion Criteria:\n\n          -  Patients who do not have aneurysm of the abdominal aorta\n\n          -  Refusal to sign the consent form for participation\n\n          -  Patients who do not wish to have their operation in Dijon or Strasbourg CHU"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Only patients of the CHU Dijon and Strasbourg"
            }
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01904825", 
            "org_study_id": "Bonnin PHRC IR 2006"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 19, 2013", 
        "number_of_groups": "1", 
        "overall_official": {
            "affiliation": "CHU Dijon - Biological Resource Center", 
            "last_name": "Alain BONNIN", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "Unspecified"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Quality sentinel cells", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01904825"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire Dijon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Dijon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2006", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Day", 
        "verification_date": "July 2013"
    }
}